NYSE: EHAB
Enhabit, Inc. (NYSE: EHAB) is a national home health and hospice care provider operating 249 home health locations and 117 hospice locations across 34 states with approximately 10,800 employees. The company provides Medicare, Medicare Advantage, managed care, and Medicaid-funded home health services including skilled nursing, therapy, and medical social work, as well as hospice services for end-of-life care. Enhabit serves as a trusted partner to health systems, payers, and risk-bearing entities, leveraging standardized clinical protocols, disciplined use of technology, and motivated clinicians to deliver cost-effective, high-quality home-based care. The company generates revenue primarily from Medicare (64.1% in Q4 2025) and Medicare Advantage (24.9%), with managed care accounting for 9.5%. In February 2026, Enhabit announced a definitive agreement to be acquired by Kinderhook Industries, a middle-market private equity firm, for $13.80 per share in cash, representing approximately $1.1 billion in total enterprise value, with the transaction expected to close in Q2 2026. Updated
With the CBOE Volatility Index (VIX) sitting at 25.50 and up 34.9% over the past month, investors are increasingly rotating toward names that offer stability, predictable income, and low correlation to broader…
Wednesday's top analyst upgrades and downgrades included Amazon.com, BioMarin Pharmaceutical, Constellation Brands, Dominion Energy, Lucid, Nike, Southern Company, Tesla, Valero Energy, Walgreens Boots Alliance and Wells Fargo.
Enhabit, Inc. (NYSE: EHAB) is a national home health and hospice care provider operating 249 home health locations and 117 hospice locations across 34 states with approximately 10,800 employees.
